Laboratory reports are available for selected lots. Check each report for its result and stated method.
PT-141
≥98% Purity
Class-level spec; selected lots third-party tested
COA Available
Batch report on request · HPLC identity check
Size
10mg
= Lab report published
€39.99
1
Total: €39.99
Free shipping on orders over €200
- If a product does not match the specification on its published COA, contact us with your batch number: we investigate against the lot report and replace any product that fails it, at no cost to you.
- Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.
3–7 days most of the EU · 10–14 Nordics/Baltics
Standard EU from €4.99 · core EU GLS €17.99 · Dispatched within 1–2 business days · Free shipping over €200 · no customs paperwork (EU).
How Paysera and SEPA work
- Pay: send a manual SEPA transfer using the IBAN we email you, or approve a SEPA transfer via Paysera where offered.
- We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
- We dispatch — confirmed orders typically ship within 1–2 business days.
Card payments are not currently offered.
Research-grade PT-141 (Bremelanotide) for laboratory research. For research purposes only. Not for human consumption.
Volume Pricing
Applied automatically at checkout
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €39.99 | €39.99 | — |
| 3+ | €37.99 | €113.97 | 5% off |
| 5+ Most Popular | €35.99 | €179.96 | 10% off |
| 10+ | €33.99 | €339.92 | 15% off |
Class-level specification on record; independent testing on selected lots.
Dispatched within 1–2 business days, shipping from €4.99 in the EU.
Ships across the EU plus Switzerland and the UK where permitted.
PT-141 10 mg Peptide
PT-141 10 mg is the development code for bremelanotide, a synthetic cyclic heptapeptide derived from Melanotan II, supplied as a lyophilised powder. In studies of the compound it acts at melanocortin receptors, including MC1R, MC3R, and MC4R. The approved bremelanotide medicine has been studied for hypoactive sexual desire disorder in premenopausal women, with reported effects on desire and arousal. Those findings concern that drug and its formulation, not this vial, and they are not a dosing guide. 10 mg is the labelled content. For laboratory research only. Not for human or veterinary administration.
What Are PT-141 and Bremelanotide?
PT-141 is the development code for bremelanotide, a synthetic cyclic heptapeptide derived from Melanotan II. Its structure makes it relevant to comparative studies of melanocortin compounds and their interactions with receptors.
Bremelanotide is a melanocortin receptor agonist that activates several subtypes, including MC1R, MC4R and MC3R. It should therefore not be described as selectively isolating one receptor’s activity without appropriate experimental controls.
Research Applications of PT-141
PT-141 can be investigated in receptor-expressing models to examine binding, activation and downstream signal responses. Experiments using PT-141 should account for the receptors present, exposure time and assay conditions.
Comparative work may examine how cyclic peptide structures influence activity. A measured signal does not independently establish which pathway produced the response, so suitable controls are important when interpreting PT-141 results.
The 10mg quantity describes the labelled content, not an experimental dose or a guarantee of suitability for every protocol.
Quality and Analytical Documentation
For PT-141, review the HPLC result alongside available identity-testing records. A reported purity percentage applies to the tested sample and method; it does not independently establish peptide quantity, sterility or stability.
Match the certificate to the supplied vial and confirm that any advertised independent testing is supported by the relevant report. Avoid transferring analytical results from another batch or formulation.
PT-141 Reconstitution and Storage
Keep the lyophilised material sealed and follow the supplier’s documented storage conditions. Before you reconstitute the contents, confirm the solvent and concentration required by your validated protocol.
Bacteriostatic water should be used only where its composition is compatible with the peptide and assay. Record reconstitution details and follow product-specific instructions for prepared solutions rather than assuming a universal four-week shelf life.
This product is supplied for in-vitro laboratory research use only, not for human or veterinary administration. An approved medicine containing bremelanotide does not confer equivalent status on a separately supplied research reagent.
Related Studies:
Product Specifications
- Form: Lyophilized powder
- Purity: ≥98% (class-level specification)
- Storage: −20°C, protected from light
- Intended use: Laboratory research only
- Documentation: Batch certificate of analysis on request
COA Analysis
Selected lots are independently tested. Request the certificate for your batch number before the material enters an assay. Identity should match the stated sequence on the vial label.
For research purposes only. Not for human consumption.
Handling & Storage
Check the lot number against the certificate before the material enters an assay. Reconstitute only when the protocol calls for a working solution, using the solvent and concentration that protocol specifies. A prepared solution is not assumed to have the same storage life as the dry vial.
Store sealed vials at −20°C, protected from light and moisture. For research use only. Not for human or animal administration.
